Dendritic cells continue to capture and present antigens after maturation in vivo.
about
Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cellsA novel cancer therapeutic using thrombospondin 1 in dendritic cellsCD14 controls the LPS-induced endocytosis of Toll-like receptor 4Intracellular regulation of cross-presentation during dendritic cell maturation.Therapeutic effect of intratumoral injections of dendritic cells for locally recurrent gastric cancer: a case report.HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1Nanoliposomes of L-lysine-conjugated poly(aspartic acid) Increase the Generation and Function of Bone Marrow-derived Dendritic CellsExogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic CellsFrom optical bench to cageside: intravital microscopy on the long road to rational vaccine design.Inflammatory spleen monocytes can upregulate CD11c expression without converting into dendritic cells.Presentation of phagocytosed antigens by MHC class I and II.Mycobacterium bovis DNA detection in colostrum as a potential indicator of vaccination effectiveness against bovine tuberculosisMitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense.Co-ordination of incoming and outgoing traffic in antigen-presenting cells by pattern recognition receptors and T cells.Dendritic cell-targeted vaccines.The ins and outs of MHC class II-mediated antigen processing and presentation.The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.Dendritic cell maturation and cross-presentation: timing matters!Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties.TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation.Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8+ T-cell effector differentiation by IL-2 modulation.Intracellular events regulating cross-presentation.Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide.Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8+ Immunity In Vivo.Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset.Glucocorticoid-Induced Leucine Zipper Protein Controls Macropinocytosis in Dendritic Cells.Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity.MAP1981c, a Putative Nucleic Acid-Binding Protein, Produced by Mycobacterium avium subsp. paratuberculosis, Induces Maturation of Dendritic Cells and Th1-Polarization.Trial watch: DNA-based vaccines for oncological indicationsDEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells
P2860
Q27319569-263B4840-FF0D-4683-8BF5-9B47692CD4E7Q28081740-B252290D-912E-490B-A777-DDE878D5E7FBQ28395685-84B57EDA-A78C-47B7-B6A2-CCBD9087D5FCQ28594101-C2D4432F-8265-4CB0-A513-CBDB5CE46761Q35009666-6CF121F3-0A44-4392-9773-90D00CDDB5C2Q35060147-24E54995-A72C-40E5-BA89-3BF35FE2E4DBQ35208189-E8EAA7F0-8C40-40DD-8A36-D0EA335CC619Q35624557-B50BCAB4-1DEE-488F-8B16-842EE3D6E4AFQ35951395-082D5594-D3F6-4CC4-BFA7-1B07449ECA14Q36108239-A5513B37-ED9F-409D-B6E1-F9CB3E30C214Q36126087-F6A9799D-71E5-48E8-9D62-AC1D98D3D233Q36514286-7991E3D6-493E-48DD-9B43-AF4A30878061Q36757791-8E989EF4-DF3E-4B1F-8DF6-343810ED28CEQ37197479-F9EA1556-4A8E-4BF1-A9F4-4AAD6A9BE969Q37901573-860BCDF6-0643-4532-9374-16C3D3557D79Q38218671-779487DA-FEC3-48EE-A23C-70C58EFE7B75Q38365560-06C50B95-871C-4D80-8DEC-99A84C80EAF4Q38869721-91C5ABDC-80F6-44AD-BCC0-754159DDA05FQ38869727-A030F41E-FB49-4381-977A-BE2E3CF6EEA2Q39616830-18CFD586-B0B6-4A14-BD4B-E73CE7E07A12Q40227414-375706BA-0C47-41B9-A5BB-F41627EB5EA7Q41869061-F64246AF-28AE-4F89-904D-4781A26D3DBAQ42183323-55C1B098-323E-43DB-99B6-1201782DCC8EQ44599389-8C2884E6-8B2C-4E81-8146-F13B3B5B59F8Q47137503-29660930-CECB-4BC4-BEEC-E438E92DBFC7Q47550123-4683E661-6F7F-43D0-B6C9-36DF1317D6A9Q48264536-76E5D296-5050-456C-8DCA-DF418F9C8E56Q49242675-0ABE9905-9980-48E0-AB76-465369DA9D02Q55416755-6BA2AC1C-0F95-4D93-8FA7-6474132B8484Q56893452-B647B069-4389-402D-9CAB-18224E4F3E57Q58619914-AC9534FC-F137-42FB-8AB6-3E4999DB2616
P2860
Dendritic cells continue to capture and present antigens after maturation in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dendritic cells continue to capture and present antigens after maturation in vivo.
@ast
Dendritic cells continue to capture and present antigens after maturation in vivo.
@en
Dendritic cells continue to capture and present antigens after maturation in vivo.
@nl
type
label
Dendritic cells continue to capture and present antigens after maturation in vivo.
@ast
Dendritic cells continue to capture and present antigens after maturation in vivo.
@en
Dendritic cells continue to capture and present antigens after maturation in vivo.
@nl
prefLabel
Dendritic cells continue to capture and present antigens after maturation in vivo.
@ast
Dendritic cells continue to capture and present antigens after maturation in vivo.
@en
Dendritic cells continue to capture and present antigens after maturation in vivo.
@nl
P2860
P356
P1476
Dendritic cells continue to capture and present antigens after maturation in vivo.
@en
P2093
E Sergio Trombetta
Scott B Drutman
P2860
P304
P356
10.4049/JIMMUNOL.1000642
P407
P577
2010-07-19T00:00:00Z